TSBX
Income statement / Annual
Last year (2024), Turnstone Biologics Corp.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Turnstone Biologics Corp.'s net income was -$70.84 M.
See Turnstone Biologics Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$19.31 M |
$73.30 M |
$101.29 M |
| Cost of Revenue |
$1.84 M
|
$2.80 M
|
$2.20 M
|
$2.01 M
|
| Gross Profit |
-$1.84 M
|
$16.51 M
|
$71.10 M
|
$99.28 M
|
| Gross Profit Ratio |
0
|
0.85
|
0.97
|
0.98
|
| Research and Development Expenses |
$56.10 M
|
$60.49 M
|
$84.50 M
|
$52.74 M
|
| General & Administrative Expenses |
$16.39 M
|
$17.85 M
|
$18.22 M
|
$13.55 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$16.39 M
|
$17.85 M
|
$18.22 M
|
$13.55 M
|
| Other Expenses |
-$1.01 M
|
-$3.70 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$71.48 M
|
$74.64 M
|
$102.73 M
|
$66.29 M
|
| Cost And Expenses |
$73.32 M
|
$77.44 M
|
$104.93 M
|
$68.30 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.84 M
|
$2.80 M
|
$2.20 M
|
$2.01 M
|
| EBITDA |
-$68.97 M |
-$56.23 M |
-$28.49 M |
$35.71 M |
| EBITDA Ratio |
0
|
-2.91
|
-0.39
|
0.35
|
| Operating Income Ratio |
0
|
-3.01
|
-0.43
|
0.33
|
| Total Other Income/Expenses Net |
$1.69 M
|
$2.65 M
|
$933.00 K
|
$708.00 K
|
| Income Before Tax |
-$70.80 M
|
-$55.49 M
|
-$30.69 M
|
$33.70 M
|
| Income Before Tax Ratio |
0
|
-2.87
|
-0.42
|
0.33
|
| Income Tax Expense |
$37.00 K
|
-$286.00 K
|
$141.00 K
|
$432.00 K
|
| Net Income |
-$70.84 M
|
-$55.20 M
|
-$30.83 M
|
$33.27 M
|
| Net Income Ratio |
0
|
-2.86
|
-0.42
|
0.33
|
| EPS |
-3.07 |
-2.73 |
-1.39 |
1.5 |
| EPS Diluted |
-3.07 |
-2.73 |
-1.39 |
1.5 |
| Weighted Average Shares Out |
$23.04 M
|
$20.20 M
|
$22.19 M
|
$22.19 M
|
| Weighted Average Shares Out Diluted |
$23.04 M
|
$20.20 M
|
$22.19 M
|
$22.19 M
|
| Link |
|
|
|
|
